Device Trial Radar · NCT04976907
Peri-operative Mobile Application for Contactless Screening and Vital Signs Measurement
Last checked: Nov 20, 2026Latest source record: Sep 14, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
200
Planned (sponsor's estimate)
Start
Oct 1, 2021
Primary completion
Oct 1, 2022
Study completion Oct 1, 2022
Sponsor
- Lead sponsor
- Nuralogix CorporationNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- University Health Network, Toronto; Hamilton Health Sciences Corporation
- First posted
- Jul 26, 2021
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
Summary
As written by the sponsor on the registry.
The impact of the coronavirus disease (COVID)-19 pandemic on global healthcare systems has prompted a search for novel tools to stem the tide. New digital health tools can provide possible health solutions in this time of unprecedented medical crisis to mitigate the impact of this pandemic. This proof of concept study will determine the feasibility and effectiveness of implementing a mobile application for contactless screening and vital signs measurement (MAC-VITAL) such as blood pressure (BP), heart rate (HR), respiratory rate (RR), oxyhemoglobin saturation (SpO2), temperature from surgical patients peri-operatively. Contactless measurement of vital signs will bridge the current gap between virtual care and in-person medical assessments.
Conditions
- Vital Signs
Interventions
Contactless vital sign information collectionDevice
Collection of facial blood flow and temperature information via conventional and infrared/thermal video of the face for the purpose of estimating vital signs using machine learning-based computational models.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Systolic blood pressure difference from reference measurement (mmHg)Time frame: Perioperative
- Diastolic blood pressure difference from reference measurement (mmHg)Time frame: Perioperative
- Blood oxygenation (SpO2) difference from reference measurement (% oxyhemoglobin saturation)Time frame: Perioperative
4 more outcomes with a free account
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Hamilton General Hospital (Hamilton Health Sciences)
Hamilton, Ontario, Canada
Juravinski Hospital (Hamilton Health Sciences)
Hamilton, Ontario, Canada
Toronto General Hospital
Toronto, Ontario, Canada
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.